Close
Nordic 9Nordic 9

Draupnir Bio (private company)

Denmark draupnir.bio
See something wrong or missing? Let us know
Offices:Aarhus
Registration number:38546880
Industry:BiotechHealth services
Business model:B2B

Draupnir Bio was set out to develop a new type of cholesterol-lowering medicine and developed a platform for exploring the glycome to develop novel therapeutics. The platform is based on array technology, protein chemistry and advanced carbohydrate chemistry.

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 46.13M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Draupnir Bio

Name Criteria
Denmark AFYX Therapeutics
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Algenex
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden EnginZyme
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom LabGenius
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark MedTrace
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Top